About Nymak Pharma Private Limited
Data last updated:
Nymak Pharma Private Limited is a private limited company based in Mundra, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33110GJ2014PTC080874.
The company has an authorised share capital of ₹2.65 Cr and a paid-up capital of ₹50 Lakh. It was formerly known as Nymak Pharma Limited. It is led by directors including Ranjit Sundersing Advani and Deepa Haresh Advani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 22 Port Bizz Phase No 3 First Floor, Sr No 343 393/1 394 395/1 395/2 401/P1 401/2 402 Sh 06 Kandla Mundra Highway Bhadresar, Gujarat, India – 370410.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.73 Cr. For the same year it recorded a net profit of ₹13.42 Lakh (net margin 2.3%) and EBITDA of ₹35.07 Lakh (EBITDA margin 6.1%).
The company is associated with 1 brand: Nymak Pharma. As per MCA filings, the company has open charges of ₹2.5 Cr on record. The company has 1 deal on record (1 secondary share transfer); the latest was in October 2021.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nymakpharma.com.
Company details
CIN history
Nymak Pharma has one previous CIN (Corporate Identification Number): U33110GJ2014PLC080874. The current CIN is U33110GJ2014PTC080874, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33110GJ2014PTC080874 | Current |
| U33110GJ2014PLC080874 | Previous |
Contact details
Nymak Pharma Private Limited's registered office is in Mundra, Gujarat. Its website is nymakpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 22 Port Bizz Phase No 3 First Floor, Sr No 343 393/1 394 395/1 395/2 401/P1 401/2 402 Sh 06 Kandla Mundra Highway Bhadresar, Gujarat, India – 370410
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nymak Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Nymak Pharma operates one associated brand: Nymak Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and supply of IV fluids, formulations, and medical devices in global markets. | nymakpharma.com |
Financials of Nymak Pharma Private Limited
FY 2025 filings availableNymak Pharma Private Limited reported revenue of ₹5.73 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.42 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.1% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nymak Pharma Private Limited, buy the company report.
Board of directors of Nymak Pharma Private Limited
Nymak Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranjit Sundersing Advani | Director | 23 Sep 2014 | 12 Years 1 Months | Current |
| Deepa Haresh Advani | Director | 23 Sep 2014 | 12 Years 1 Months | Current |
| Haresh Ranjit Advani | Director | 23 Sep 2014 | 12 Years 1 Months | Current |
Auditor
Nymak Pharma Private Limited is audited by Satish Khushalani & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Satish Khushalani & Co. | FY 2023 | 119605 |
Shareholding
The shareholding of Nymak Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nymak Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Sep 2024 | 100980326 | Uco Bank | ₹1.9 Cr | Open | |
| 25 Sep 2024 | 100982683 | Uco Bank | ₹60 Lakh | Open |
Total charge records: 2 View all charges
Deals & funding
Nymak Pharma Private Limited has 1 deal on record (1 secondary share transfer); the latest was in October 2021.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Nymak Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nymak Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nymak Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nymak Pharma Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Bharti Vinod Nankani ceased to be Director on 17 Oct 2021.
Frequently asked questions
Nymak Pharma is an active private limited company based in Mundra, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 September 2014 (12+ years old) and is registered under CIN U33110GJ2014PTC080874.
Nymak Pharma has 3 current directors:
- Ranjit Sundersing Advani - Director
- Deepa Haresh Advani - Director
- Haresh Ranjit Advani - Director
The latest financial statements of Nymak Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Nymak Pharma is U33110GJ2014PTC080874. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nymak Pharma was incorporated on 23 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Nymak Pharma has 1 deal on record (1 secondary share transfer); the latest was in October 2021.
Bharti Vinod Nankani ceased to be Director on 17 Oct 2021. Vinod Tarachand Nankani ceased to be Director on 17 Oct 2021. Deepa Haresh Advani was appointed as Director on 23 Sep 2014. Nymak Pharma has 5 board changes on record in total.
Nymak Pharma can be reached through the website nymakpharma.com. Its registered office is in Mundra, Gujarat, India.
The registered office of Nymak Pharma is at Plot No 22 Port Bizz Phase No 3 First Floor, Sr No 343 3931 394 3951 3952 401P1 4012 402 Sh 06 Kandla Mundra Highway Bhadresar, Gujarat, India – 370410.
Nymak Pharma operates in the pharma industry, in the drug formulation and development segment.